Pfizer Inc to Present at 42nd Annual J.P. Morgan Healthcare Conference
On Monday, January 8, 2024, Pfizer Inc. (NYSE:PFE) announced that its Chairman and Chief Executive Officer, Albert Bourla, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference. The event will take place at 3:00 p.m. PST. The webcast will be available for at least 90 days.
Pfizer is a global biopharmaceutical company that is dedicated to bringing therapies to people that extend and significantly improve their lives. With a strong focus on quality, safety, and value, Pfizer works tirelessly to discover, develop, and manufacture innovative medicines and vaccines. The company’s efforts to advance wellness, prevention, treatments, and cures for the most feared diseases of our time are evident in its more than 170 years of making a difference for all who rely on them.
During the webcast, Pfizer may discuss its product pipeline, in-line products and product candidates, revenue projections, and potential market dynamics. These statements are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Pfizer assumes no obligation to update these forward-looking statements as the result of new information or future events or developments.
Pfizer’s Chairman and CEO, Albert Bourla, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 p.m. PST.
